GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » Research & Development

DRI Healthcare Trust (TSX:DHT.U) Research & Development : $0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. DRI Healthcare Trust's Research & Development for the three months ended in Mar. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

DRI Healthcare Trust Research & Development Historical Data

The historical data trend for DRI Healthcare Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Research & Development Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DRI Healthcare Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DRI Healthcare Trust  (TSX:DHT.U) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DRI Healthcare Trust Research & Development Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

DRI Healthcare Trust (TSX:DHT.U) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » Research & Development
Comparable Companies
XCNQ:CL TSX:WEED TSX:TSND TSX:GUD NEOE:GLAS.A.U XCNQ:AAWH.U TSX:ACB XCNQ:EPIC TSX:CRON XCNQ:IAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
DHTRF:USA DHT.UN:Canada
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
Website
https://www.dricapital.com
DRI Healthcare Trust is a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions, and biopharma companies. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world.

DRI Healthcare Trust (TSX:DHT.U) Headlines

No Headlines